CLINICAL TRIALS PROFILE FOR RYTHMOL
✉ Email this page to a colleague
All Clinical Trials for RYTHMOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00589303 ↗ | AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study | Terminated | Medtronic | Phase 3 | 2007-12-01 | The purpose of this study is to determine whether early atrioventricular node (AVN) ablation with pacing device therapy will reduce death and hospitalization when compared to the conventional drug therapy in elderly patients with recurrent and symptomatic atrial fibrillation (AF). |
NCT00589303 ↗ | AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study | Terminated | Mayo Clinic | Phase 3 | 2007-12-01 | The purpose of this study is to determine whether early atrioventricular node (AVN) ablation with pacing device therapy will reduce death and hospitalization when compared to the conventional drug therapy in elderly patients with recurrent and symptomatic atrial fibrillation (AF). |
NCT01956487 ↗ | Bioequivalence of RYTHMOL SRĀ® Manufactured at Two Different Sites | Completed | GlaxoSmithKline | Phase 1 | 2012-04-11 | Bioequivalence of propafenone hydrochloride capsules manufactured at two different sites |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RYTHMOL
Condition Name
Clinical Trial Locations for RYTHMOL
Trials by Country
Clinical Trial Progress for RYTHMOL
Clinical Trial Phase
Clinical Trial Sponsors for RYTHMOL
Sponsor Name